Clinical Trials Directory

Trials / Completed

CompletedNCT01945567

Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor

Randomised Crossover Trial of Deep Brain Stimulation of Differential Posterior Subthalamic Area Regions in Parkinson's Disease and Tremor

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
39 (actual)
Sponsor
The University of Western Australia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The posterior subthalamic area holds promise as a target region for deep brain stimulation in tremor and Parkinson's disease. Using the magnetic resonance-directed implantable guide tube surgical technique, subregions of the posterior subthalamic area can be individually targetted on a single electrode lead trajectory. The hypothesis is that the caudal zona incerta may provide improved control of movement disorder symptoms than the more commonly stimulated dorsal zona incerta.

Detailed description

Randomisation between two treatment locations each programmed up to 3 milliamps in amplitude for 3 months: (1) caudal zona incerta and (2) dorsal zona incerta. This 6-month-long randomised phase is followed by 6 months of unblinded individualised empirically optimised settings programmed by a neurologist. Each of the three treatment periods ends with a full clinical, functional and quality of life assessment.

Conditions

Interventions

TypeNameDescription
DEVICEUp to 3 mA, 60 us, 130 Hz deep brain stimulation
DEVICEEmpirical unblinded deep brain stimulation programming

Timeline

Start date
2012-08-01
Primary completion
2019-08-30
Completion
2020-08-30
First posted
2013-09-18
Last updated
2021-05-18

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT01945567. Inclusion in this directory is not an endorsement.